AI selecteert kankerpatiënten die baat hebben bij immunotherapie
Healthcare · Amsterdam · Opgericht 2019
Wat ze bouwen
Ellogon.AI is an Amsterdam-based MedTech startup specializing in AI applications for healthcare, particularly in cancer immunotherapy. The company develops predictive AI technology and automated biomarkers from pathology biopsies and genomic data to transform oncology drug development. Their flagship EIDOS™ solution assists medical experts in precisely selecting patients who are most likely to benefit from immunotherapy, aiming to improve patient outcomes and ensure accessible, affordable healthcare. Developed in collaboration with the Netherlands Cancer Institute, EIDOS™ is CE-IVDD certified and currently in use in four Dutch academic hospitals and one Greek hospital.
De mensen erachter
Wie erin gelooft
Ellogon.AI haalde in totaal €1M op. De laatste bekende ronde is Seed.
Waar ze zitten
Omgeving laden…
Verder kijken